|
NDC00074-5729-11
|
6505-01-321-4726
|
Erythromycin Ethylsuccinate Tabl |
Abbott Laboratories
|
|
Quote
|
|
NDC51285-0554-02
|
6505-01-321-5232
|
Trimipramine Maleate Capsules |
Duramed Pharmaceuticals Inc
|
|
Quote
|
|
NDC45802-0055-05
|
6505-01-321-5235
|
Triamcinolone Acetonide Ointment |
Perrigo Company
|
|
Quote
|
|
A90L083
|
6505-01-321-5857
|
Usp Sulindac Tablets |
Department of the Army
|
|
Quote
|
|
NDC00364-2441-05
|
6505-01-321-5857
|
Usp Sulindac Tablets |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC00364-2441-05
|
6505-01-321-5857
|
Usp Sulindac Tablets |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-2441-05
|
6505-01-321-5857
|
Usp Sulindac Tablets |
Henry Schein, Inc.
|
|
Quote
|
|
NDC00469-2290-20
|
6505-01-321-5858
|
Usp Protamine Sulfate Injection |
Lyphomed Inc
|
|
Quote
|
|
DORAL
|
6505-01-321-7751
|
Usp Quazepam Tablets |
Baker/cummins Pharmaceticals Inc
|
|
Quote
|
|
DORAL TABLETS
|
6505-01-321-7751
|
Usp Quazepam Tablets |
Baker/cummins Pharmaceticals Inc
|
|
Quote
|
|
NDC00037-9002-01
|
6505-01-321-7751
|
Usp Quazepam Tablets |
Meda Pharmaceuticals, Inc
|
|
Quote
|
|
NDC00037-9002-01
|
6505-01-321-7751
|
Usp Quazepam Tablets |
Baker/cummins Pharmaceticals Inc
|
|
Quote
|
|
DORAL
|
6505-01-321-7752
|
Usp Quazepam Tablets |
Baker/cummins Pharmaceticals Inc
|
|
Quote
|
|
DORAL TABLETS
|
6505-01-321-7752
|
Usp Quazepam Tablets |
Baker/cummins Pharmaceticals Inc
|
|
Quote
|
|
NDC00037-9000-01
|
6505-01-321-7752
|
Usp Quazepam Tablets |
Meda Pharmaceuticals, Inc
|
|
Quote
|
|
NDC00037-9000-01
|
6505-01-321-7752
|
Usp Quazepam Tablets |
Baker/cummins Pharmaceticals Inc
|
|
Quote
|
|
NDC00024-2301-10
|
6505-01-321-7754
|
Betaxolol Hydrochloride Tablets |
Sanofi Pharmaceuticals Inc
|
|
Quote
|
|
NDC00472-0242-60
|
6505-01-321-8812
|
Permethrin Cream |
Actavis Elizabeth Llc
|
|
Quote
|
|
NDC45802-0269-37
|
6505-01-321-8812
|
Permethrin Cream |
Pharmacia & Upjohn Company
|
|
Quote
|
|
PROCARDIA XL TABLETS
|
6505-01-322-2106
|
Nifedipine Extended-release Tabl |
Pfizer Inc.
|
|
Quote
|
|
PROCARDIA XL
|
6505-01-322-2106
|
Nifedipine Extended-release Tabl |
Pfizer Inc.
|
|
Quote
|
|
NDC00069-2660-72
|
6505-01-322-2106
|
Nifedipine Extended-release Tabl |
Pfizer Inc.
|
|
Quote
|
|
NDC00045-0414-70
|
6505-01-322-2369
|
Usp Tolmetin Sodium Capsules |
Mcneil Lab Inc
|
|
Quote
|
|
NDC00093-8815-05
|
6505-01-322-2369
|
Usp Tolmetin Sodium Capsules |
Schwarz Pharma Inc.
|
|
Quote
|
|
KERLONE
|
6505-01-322-3074
|
Betaxolol Hydrochloride Tablets |
Searle G D and Co
|
|
Quote
|
|
KERLONE TABLETS
|
6505-01-322-3074
|
Betaxolol Hydrochloride Tablets |
Searle G D and Co
|
|
Quote
|
|
NDC00025-5201-31
|
6505-01-322-3074
|
Betaxolol Hydrochloride Tablets |
Pharmacia & Upjohn Inc
|
|
Quote
|
|
NDC00025-5201-31
|
6505-01-322-3074
|
Betaxolol Hydrochloride Tablets |
Searle G D and Co
|
|
Quote
|
|
NDC00536-4622-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Rugby Mfg Co
|
|
Quote
|
|
NDC00364-2442-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-2442-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Henry Schein, Inc.
|
|
Quote
|
|
NDC00536-4622-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Rugby Mfg Co
|
|
Quote
|
|
NDC00364-2442-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-2442-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Henry Schein, Inc.
|
|
Quote
|
|
NDC00536-4622-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Rugby Mfg Co
|
|
Quote
|
|
NDC00364-2442-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-2442-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Henry Schein, Inc.
|
|
Quote
|
|
NDC00536-4622-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Rugby Mfg Co
|
|
Quote
|
|
NDC00364-2442-05
|
6505-01-322-4621
|
Usp Sulindac Tablets |
Schein Henry Inc
|
|
Quote
|
|
97-0827
|
6505-01-322-5891
|
Morphine Sulfate Extended-releas |
Defense Logistics Agency
|
|
Quote
|
|
MS CONTIN
|
6505-01-322-5891
|
Morphine Sulfate Extended-releas |
The Frederick Purdue Company
|
|
Quote
|
|
NDC59011-0263-10
|
6505-01-322-5891
|
Morphine Sulfate Extended-releas |
The Frederick Purdue Company
|
|
Quote
|
|
NDC00591-0780-05
|
6505-01-322-6499
|
Sucralfate Tablets |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00093-2210-05
|
6505-01-322-6499
|
Sucralfate Tablets |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00591-0780-05
|
6505-01-322-6499
|
Sucralfate Tablets |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
CARDIZEM
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM TABLETS
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00088-1771-55
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM TABLETS
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00088-1771-55
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM
|
6505-01-322-6501
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM TABLETS
|
6505-01-322-6501
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00088-1772-55
|
6505-01-322-6501
|
Usp Diltiazem Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1772-55
|
6505-01-322-6501
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
TOLECTIN 600
|
6505-01-322-8539
|
Usp Tolmetin Sodium Tablets |
Mcneil Lab Inc
|
|
Quote
|
|
TOLECTIN TABLETS
|
6505-01-322-8539
|
Usp Tolmetin Sodium Tablets |
Mcneil Lab Inc
|
|
Quote
|
|
NDC00045-0416-60
|
6505-01-322-8539
|
Usp Tolmetin Sodium Tablets |
Mcneil Pharmaceutical Co
|
|
Quote
|
|
NDC00045-0416-60
|
6505-01-322-8539
|
Usp Tolmetin Sodium Tablets |
Mcneil Lab Inc
|
|
Quote
|
|
CARAFATE
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
CARAFETE TABLETS
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1712-53
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC58914-0171-21
|
6505-01-322-9347
|
Sucralfate Tablets |
Axcan Pharma Us Inc.
|
|
Quote
|
|
CARAFATE
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
CARAFETE TABLETS
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1712-53
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC58914-0171-21
|
6505-01-322-9347
|
Sucralfate Tablets |
Axcan Pharma Us Inc.
|
|
Quote
|
|
NDC00006-0963-58
|
6505-01-322-9348
|
Usp Famotidine Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00006-0963-58
|
6505-01-322-9348
|
Usp Famotidine Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
08-6610
|
6505-01-323-2630
|
Concentrat Hemodialysis Solution |
National Medical Care
|
|
Quote
|
|
RMS
|
6505-01-323-2648
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
RMS SUPPOSITORIES
|
6505-01-323-2648
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
NDC00245-0162-12
|
6505-01-323-2648
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
NDC00054-8777-05
|
6505-01-323-2648
|
Morphine Sulfate Suppositories |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
FORTAZ
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Glaxo Wellcome Inc
|
|
Quote
|
|
FORTAZ INJECTION
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0413-00
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Glaxo Wellcome Inc
|
|
Quote
|
|
2G3536
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Baxter Healthcare Corp
|
|
Quote
|
|
2G558
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
RMS
|
6505-01-323-2650
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
NDC00245-0163-12
|
6505-01-323-2650
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
NDC00054-8778-05
|
6505-01-323-2650
|
Morphine Sulfate Suppositories |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
